2023 - Research.com Microbiology in United Kingdom Leader Award
Scott Koenig spends much of his time researching Virology, Antibody, Immunology, Virus and Monoclonal antibody. His Virology research integrates issues from Cell culture, Antigen, Immune system and Microbiology. As a member of one scientific family, Scott Koenig mostly works in the field of Antibody, focusing on Effector and, on occasion, Molecular biology, Specific antibody, In vitro and Immunotherapy.
His Immunology research incorporates themes from Cytotoxic T cell, Receptor and Acquired immunodeficiency syndrome. His specific area of interest is Virus, where Scott Koenig studies Retrovirus. His Monoclonal antibody research is multidisciplinary, incorporating elements of Cross-presentation, Fc receptor, Epitope, Interleukin 12 and In vivo.
His main research concerns Virology, Antibody, Immunology, Antigen and Molecular biology. Scott Koenig has researched Virology in several fields, including Epitope, Acquired immunodeficiency syndrome and Microbiology. His Antibody study combines topics in areas such as Cancer, Receptor, Immune system and Effector.
His Immunology research focuses on Cytotoxic T cell and how it connects with CD8, T lymphocyte, Human leukocyte antigen and Cellular immunity. In his study, Cancer cell and Antibody-drug conjugate is strongly linked to Cancer research, which falls under the umbrella field of Antigen. He has included themes like Amino acid, In vitro, Antibody-dependent cell-mediated cytotoxicity and B cell in his Molecular biology study.
His scientific interests lie mostly in Antibody, Immunology, Monoclonal antibody, Cancer research and Epitope. His Antibody research focuses on subjects like Effector, which are linked to T-cell receptor. His research in Immunology is mostly focused on Virus.
The Virus study which covers Cytotoxic T cell that intersects with Immunotherapy and Peripheral blood mononuclear cell. His Cancer research study integrates concerns from other disciplines, such as Cancer cell, Cancer, Antibody-drug conjugate and Antigen. His Virology research includes themes of Antigen binding, CD3 and Cell killing.
Antibody, Epitope, Molecular biology, Monoclonal antibody and Type 1 diabetes are his primary areas of study. The Antibody study combines topics in areas such as Cell killing, Antigen and Virology. His biological study spans a wide range of topics, including Jurkat cells and Interleukin 21, CD8, Streptamer.
The various areas that he examines in his Epitope study include Bispecific antibody, Stereochemistry and Immune system. The concepts of his Molecular biology study are interwoven with issues in Trastuzumab, Monoclonal, Cancer cell, Antibody-dependent cell-mediated cytotoxicity and Wild type. His work deals with themes such as Progenitor cell, Cancer stem cell, Cancer and CD16, which intersect with Monoclonal antibody.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.
Akio Adachi;Howard E. Gendelman;Scott Koenig;Thomas Folks.
Journal of Virology (1986)
Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy.
Scott Koenig;Howard E. Gendelman;Jan M. Orenstein;Mauro Carlo Dal Canto.
A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals.
Dennis R. Burton;Carlos F. Barbas;Mats A. A. Persson;Scott Koenig.
Proceedings of the National Academy of Sciences of the United States of America (1991)
Circulating CD8 + cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease
Steven Jacobson;Hisatoshi Shida;Dale E. McFarlin;Anthony S. Fauci.
Development of a Humanized Monoclonal Antibody (MEDI-493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus
Syd Johnson;Cynthia Oliver;Gregory A. Prince;Val G. Hemming.
The Journal of Infectious Diseases (1997)
Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination.
Solomon Langermann;Solomon Langermann;Susan Palaszynski;Susan Palaszynski;Michelle Barnhart;Michelle Barnhart;Gale Auguste;Gale Auguste.
Use of a Whole Genome Approach To Identify Vaccine Molecules Affording Protection against Streptococcus pneumoniae Infection
Theresa M. Wizemann;Jon H. Heinrichs;John E. Adamou;Alice L. Erwin.
Infection and Immunity (2001)
Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression.
Scott Koenig;Anthony J. Conley;Yambasu A. Brewah;Gary M. Jones.
Nature Medicine (1995)
Biological and biochemical characterization of a cloned leu-3− cell surviving infection with the acquired immune deficiency syndrome retrovirus
T. M. Folks;D. Powell;M. Lightfoote;S. Koenig.
Journal of Experimental Medicine (1986)
Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcγ receptors
Jeffrey B. Stavenhagen;Sergey Gorlatov;Nadine Tuaillon;Christopher T. Rankin.
Cancer Research (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: